×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CATX – perspective therapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CATX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/20
07:27 am
catx
Perspective Therapeutics (NASDAQ:CATX) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Neutral
Report
Perspective Therapeutics (NASDAQ:CATX) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
2/19
07:07 am
catx
Perspective Therapeutics (NASDAQ:CATX) was given a new $16.00 price target on by analysts at Piper Sandler. They now have an "overweight" rating on the stock.
Medium
Report
Perspective Therapeutics (NASDAQ:CATX) was given a new $16.00 price target on by analysts at Piper Sandler. They now have an "overweight" rating on the stock.
2/17
11:17 am
catx
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
Low
Report
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
2/17
07:00 am
catx
Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results
Low
Report
Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results
2/2
08:35 am
catx
Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
High
Report
Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
1/30
10:04 am
catx
Perspective Therapeutics (NASDAQ:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Medium
Report
Perspective Therapeutics (NASDAQ:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
1/30
07:17 am
catx
Perspective Therapeutics (NASDAQ:CATX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Perspective Therapeutics (NASDAQ:CATX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/13
08:03 am
catx
Perspective Therapeutics (NASDAQ:CATX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $14.00 price target on the stock.
Low
Report
Perspective Therapeutics (NASDAQ:CATX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $14.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
04:05 pm
CATX
perspective therapeutics, inc.
MISS
Report
0.0%
perspective therapeutics, inc.
8/13/2025
06:45 am
CATX
perspective therapeutics, inc.
BEAT
Report
-3.8%
perspective therapeutics, inc.
5/12/2025
04:36 pm
CATX
perspective therapeutics, inc.
BEAT
Report
-1.9%
perspective therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/12
10:51 am
catx
Form SCHEDULE 13G Perspective Therapeutics Filed by: MORGAN STANLEY
Medium
Report
Form SCHEDULE 13G Perspective Therapeutics Filed by: MORGAN STANLEY
2/9
04:40 pm
catx
Form SCHEDULE 13G Perspective Therapeutics Filed by: Commodore Capital LP
Medium
Report
Form SCHEDULE 13G Perspective Therapeutics Filed by: Commodore Capital LP
2/6
04:45 pm
catx
Form SCHEDULE 13G Perspective Therapeutics Filed by: TCG Crossover GP II, LLC
Low
Report
Form SCHEDULE 13G Perspective Therapeutics Filed by: TCG Crossover GP II, LLC
2/5
08:48 am
catx
Form SCHEDULE 13G Perspective Therapeutics Filed by: Qatar Investment Authority
Medium
Report
Form SCHEDULE 13G Perspective Therapeutics Filed by: Qatar Investment Authority
2/3
04:08 pm
catx
Form 8-K Perspective Therapeutics For: Feb 02
Low
Report
Form 8-K Perspective Therapeutics For: Feb 02
2/3
06:02 am
catx
Form 424B5 Perspective Therapeutics
Medium
Report
Form 424B5 Perspective Therapeutics
2/2
07:45 am
catx
Form FWP Perspective Therapeutics Filed by: Perspective Therapeutics, Inc.
High
Report
Form FWP Perspective Therapeutics Filed by: Perspective Therapeutics, Inc.
2/2
07:45 am
catx
Form 8-K Perspective Therapeutics For: Feb 02
High
Report
Form 8-K Perspective Therapeutics For: Feb 02
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: